跳至主要内容
临床试验/CTRI/2023/05/052690
CTRI/2023/05/052690尚未招募2 期

Efficacy of Nasya and Snehapana on Greevastambha with special reference to Cervical Spondylosis: An open-labelled randomized parallel group clinical trial.

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients suffering from the classical sign and symptoms of cervical spondylosis.
  • 2)Patients of either sex between the age group of 30 to 60 years.
  • 3)Patients willing to provide written consent and able to participate in the study for 14 days and follow up for a period of 15 days.
  • 4)Patient fit for Nasya Karma and Snehapana.

排除标准

  • 1)Pregnant women and lactating mothers.
  • 2)Patients suffering from uncontrolled systemic disorders such as Hypertension, Diabetes Mellitus and other systemic diseases which affect bones and joint conditions such as Rheumatoid arthritis.
  • 3)Previous history of neck trauma, cervical fracture and surgery.
  • 4)Cervical myelopathy.

研究者

相似试验